✦ LIBER ✦

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

✍ Scribed by Manfred Johannsen; Anne Flörcken; Axel Bex; Jan Roigas; Marco Cosentino; Vincenzo Ficarra; Christian Kloeters; Matthias Rief; Patrik Rogalla; Kurt Miller; Viktor Grünwald

Book ID: 113611165
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 539 KB
Volume: 55
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2008.10.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Editorial Comment on: Can Tyrosine Kinas

Editorial Comment on: Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

✍ Aristotle Bamias 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Sequential Use of the Tyrosine Kinase In

Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis

✍ Christian Eichelberg; Roman Heuer; Felix K. Chun; Kristin Hinrichs; Mario Zachar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Sarcomatoid Dedifferentiation in Metasta

Sarcomatoid Dedifferentiation in Metastatic Clear Cell Renal Cell Carcinoma and Outcome on Treatment With Anti–Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: A Retrospective Analysis

✍ Beuselinck, Benoit; Lerut, Evelyne; Wolter, Pascal; Dumez, Herlinde; Berkers, Jo 📂 Article 📅 2014 🏛 CIG Media Group, LP. 🌐 English ⚖ 163 KB

Angiotensin system inhibitors and outcom

Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination

✍ Daniel Keizman; Peng Huang; Mario A. Eisenberger; Roberto Pili; Jenny J. Kim; Em 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 246 KB

Treatment with tyrosine kinase inhibitor

Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients

✍ Philipp Ivanyi; Thomas Winkler; Anika Großhennig; Christoph Reuter; Axel S. Mers 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 389 KB

1143 Treatment of patients with metastat

1143 Treatment of patients with metastatic papillary-type II and clear-cell renal cell carcinoma – comparison of the survival with tyrosine kinase inhibitors

✍ Casuscelli, J.; Szabados, B.; Buchner, A.; Stief, C.G.; Staehler, M. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 199 KB